But it’s not a $21M deal. They were entitled to their share of Antigen which should have been 2.1M shares. They got 5.5M shares. So an extra 3.4M shares of Antigen. That is certainly their interest, OID, etc.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.